Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Genetics|April 11, 2022
Expanded CUG Repeat RNA Induces Premature Senescence in Myotonic Dystrophy Model CellsYuhei Hasuike, Hideki Mochizuki, Masayuki Nakamori
International Journal of Molecular Sciences|February 26, 2022
Cellular Senescence and Aging in Myotonic DystrophyYuhei Hasuike, Hideki Mochizuki, Masayuki Nakamori
Rinsho Shinkeigaku = Clinical Neurology|March 31, 2016
A case of central nervous system relapse in acute promyelocytic leukemiaYuhei Hasuike, Hiroshi Yamaguchi, Hideki Mitsui, et al.
Rinsho Shinkeigaku = Clinical Neurology|October 2, 2018
[Cerebral embolism in Duchenne muscular dystrophy after respiratory tract infection - Report of two cases]Yuhei Hasuike, Toshio Saito, Tomoko Saito, et al.
Medical Hypotheses|November 4, 2019
Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson's diseaseYuhei Hasuike, Takuyuki Endo, Michiyo Koroyasu, et al.
Brain Communications|June 30, 2022
Cell type-specific abnormalities of central nervous system in myotonic dystrophy type 1Masayuki Nakamori, Hiroshi Shimizu, Kotaro Ogawa, et al.
Neurobiology of Disease|December 30, 2021
CAG repeat-binding small molecule improves motor coordination impairment in a mouse model of Dentatorubral-pallidoluysian atrophyYuhei Hasuike, Hana Tanaka, Terence Gall-Duncan, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|April 5, 2014
Photochemical behavior of single-walled carbon nanotubes in the presence of propylamineYutaka Maeda, Yuhei Hasuike, Kei Ohkubo, et al.
Eclinicalmedicine|February 5, 2024
Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialMasayuki Nakamori, Daisaku Nakatani, Tomoharu Sato, et al.
Pageof 1